177 related articles for article (PubMed ID: 38482417)
1. The value of a panel of circulating microRNAs in screening prostate cancer.
Sun C; Lu C; Li X; Li R; Wen Z; Ge Z; Chen W; Li Y; Sun S; Yang Q; Tao L; Li H; Lai Y
Transl Cancer Res; 2024 Feb; 13(2):686-698. PubMed ID: 38482417
[TBL] [Abstract][Full Text] [Related]
2. Identification of a four-microRNA panel in serum for screening renal cell carcinoma.
Chen X; Li R; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y
Pathol Res Pract; 2021 Nov; 227():153625. PubMed ID: 34628264
[TBL] [Abstract][Full Text] [Related]
3. Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study.
Lu C; Lin S; Wen Z; Sun C; Ge Z; Chen W; Li Y; Zhang P; Wu Y; Wang W; Chen S; Zhou H; Li X; Li H; Tao L; Hu Y; Zhao Z; Chen Z; Wu X; Lai Y
Biomarkers; 2024 May; ():1-9. PubMed ID: 38767408
[TBL] [Abstract][Full Text] [Related]
4. The value of a three-microRNA panel in serum for prostate cancer screening.
Lin S; Sun C; Li R; Lu C; Li X; Wen Z; Ge Z; Chen W; Li Y; Li H; Lai Y
Int J Biol Markers; 2024 Mar; 39(1):70-79. PubMed ID: 37960876
[TBL] [Abstract][Full Text] [Related]
5. Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test.
Li R; Xia Y; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Li M; Lin Y; Dong J; Ji L; Lai Y
Transl Cancer Res; 2022 May; 11(5):1005-1016. PubMed ID: 35706801
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-410-5p as a potential serum biomarker for the diagnosis of prostate cancer.
Wang J; Ye H; Zhang D; Hu Y; Yu X; Wang L; Zuo C; Yu Y; Xu G; Liu S
Cancer Cell Int; 2016; 16():12. PubMed ID: 26900347
[TBL] [Abstract][Full Text] [Related]
7. Study on identification of a three-microRNA panel in serum for diagnosing neonatal early onset sepsis.
Zhao Y; Lu C; Zhu R; Hu X
J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2280527. PubMed ID: 37968923
[TBL] [Abstract][Full Text] [Related]
8. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
[TBL] [Abstract][Full Text] [Related]
9. A Three-microRNA Panel in Serum: Serving as a Potential Diagnostic Biomarker for Renal Cell Carcinoma.
Huang G; Li X; Chen Z; Wang J; Zhang C; Chen X; Peng X; Liu K; Zhao L; Lai Y; Ni L
Pathol Oncol Res; 2020 Oct; 26(4):2425-2434. PubMed ID: 32556891
[TBL] [Abstract][Full Text] [Related]
10. A Panel of Three Serum MicroRNAs as a Potential Diagnostic Biomarker for Urothelial Carcinoma.
Li H; Huang G; Lai Y; Ni L; Lai Y
Oncol Res Treat; 2022; 45(6):344-352. PubMed ID: 35231919
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a urinary microRNA biomarker panel as a tool for early detection of prostate cancer in a Chinese population.
Zhang N; Wang J; Zhang S; Wu H; Li Z; Hu M
Biomarkers; 2023 Jun; 28(4):372-378. PubMed ID: 37185057
[TBL] [Abstract][Full Text] [Related]
12. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E
Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272
[TBL] [Abstract][Full Text] [Related]
13. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
14. Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase.
Tan Y; Ge G; Pan T; Wen D; Gan J
Clin Chim Acta; 2015 Dec; 451(Pt B):232-9. PubMed ID: 26483130
[TBL] [Abstract][Full Text] [Related]
15. A panel of three serum microRNA can be used as potential diagnostic biomarkers for nasopharyngeal carcinoma.
Li R; Lu C; Yang W; Zhou Y; Zhong J; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Hu H; Lai Y
J Clin Lab Anal; 2022 Feb; 36(2):e24194. PubMed ID: 35028969
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
17. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
[TBL] [Abstract][Full Text] [Related]
18. Identification of Key MicroRNAs and Mechanisms in Prostate Cancer Evolution Based on Biomarker Prioritization Model and Carcinogenic Survey.
Lin Y; Miao Z; Zhang X; Wei X; Hou J; Huang Y; Shen B
Front Genet; 2020; 11():596826. PubMed ID: 33519899
[No Abstract] [Full Text] [Related]
19. A Four-MicroRNA Panel in Serum as a Potential Biomarker for Screening Renal Cell Carcinoma.
Li R; Lu C; Li X; Chen X; Huang G; Wen Z; Li H; Tao L; Hu Y; Zhao Z; Chen Z; Lai Y
Front Genet; 2022; 13():897827. PubMed ID: 35938021
[No Abstract] [Full Text] [Related]
20. MicroRNA panel in serum reveals novel diagnostic biomarkers for prostate cancer.
Zhang S; Liu C; Zou X; Geng X; Zhou X; Fan X; Zhu D; Zhang H; Zhu W
PeerJ; 2021; 9():e11441. PubMed ID: 34055487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
